Is entrectinib available in China? Can it be reimbursed?

Entrectinib was approved for marketing by the China Food and Drug Administration in 2022 July . Currently, entrectinib has been included in medical insurance and can be reimbursed. Entrectinib is indicated for the treatment of adults with metastatic ROS1-positive non-small cell lung cancer. Entrectinib is also indicated in adults and children 12 years of age and older for the treatment of NTRK gene fusion-positive solid tumors that have metastasized or where surgical resection may result in significant morbidity and have progressed on prior therapy or for which no comparable alternative therapies are available.

Entrectinib is available as an oral capsule. Usually taken once daily, with or without food. Take entrectinib at about the same time each day. Follow the directions on your prescription label carefully and ask your doctor to explain any parts you don't understand. Take entrectinib exactly as directed. Do not take more or less than your doctor recommends. Swallow capsules wholeDo not open, chew or crush them. If you vomit immediately after taking entrectinib, take another dose as soon as possible. If serious side effects of entrectinib occur, your doctor may temporarily or permanently stop treatment or reduce the dose. Enrectiniband its active metabolites inhibit several pathways that contribute to cell survival and proliferation. This inhibition changes the balance in favor of apoptosis, thereby preventing cancer cell growth and shrinking tumors. There are generic drugs in Laos, the officially marketed version, with government approval, retail price of pharmaceuticals in Laos and ASEAN200mg90tablets20000yuan, 100mg30 tablets6500yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0